Bangkok Lab & Cosmetic PCL
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Myanmar, and internationally. The company distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary fo… Read more
Bangkok Lab & Cosmetic PCL (BLC) - Net Assets
Latest net assets as of June 2024: ฿1.63 Billion THB
Based on the latest financial reports, Bangkok Lab & Cosmetic PCL (BLC) has net assets worth ฿1.63 Billion THB as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿2.17 Billion) and total liabilities (฿544.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿1.63 Billion |
| % of Total Assets | 74.95% |
| Annual Growth Rate | 177.91% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 215.31 |
Bangkok Lab & Cosmetic PCL - Net Assets Trend (2021–2023)
This chart illustrates how Bangkok Lab & Cosmetic PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bangkok Lab & Cosmetic PCL (2021–2023)
The table below shows the annual net assets of Bangkok Lab & Cosmetic PCL from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ฿1.60 Billion | +466.71% |
| 2022-12-31 | ฿281.51 Million | +36.09% |
| 2021-12-31 | ฿206.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bangkok Lab & Cosmetic PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 11767370900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿98.30 Million | 6.24% |
| Other Components | ฿1.48 Billion | 93.76% |
| Total Equity | ฿1.58 Billion | 100.00% |
Bangkok Lab & Cosmetic PCL Competitors by Market Cap
The table below lists competitors of Bangkok Lab & Cosmetic PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Diamond Citra Propertindo PT
JK:DADA
|
$12.24 Million |
|
Compania General de Electricidad SA
SN:CGE
|
$12.24 Million |
|
Inch Kenneth Kajang Rubber PLC
KLSE:2607
|
$12.25 Million |
|
TWay Holdings
KO:004870
|
$12.25 Million |
|
FN REPUBLIC Co. Ltd
KQ:064090
|
$12.24 Million |
|
Galane Gold Ltd
OTCQB:GGGOF
|
$12.23 Million |
|
Senetas Corporation Ltd
AU:SEN
|
$12.23 Million |
|
Aqua Metals Inc
NASDAQ:AQMS
|
$12.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bangkok Lab & Cosmetic PCL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 268,259,574 to 1,575,596,157, a change of 1,307,336,583 (487.3%).
- Net income of 145,392,458 contributed positively to equity growth.
- Dividend payments of 79,467,280 reduced retained earnings.
- New share issuances of 1,260,000,000 increased equity.
- Other factors decreased equity by 18,588,595.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿145.39 Million | +9.23% |
| Dividends Paid | ฿79.47 Million | -5.04% |
| Share Issuances | ฿1.26 Billion | +79.97% |
| Other Changes | ฿-18.59 Million | -1.18% |
| Total Change | ฿- | 487.34% |
Book Value vs Market Value Analysis
This analysis compares Bangkok Lab & Cosmetic PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.62x to 1.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | ฿0.33 | ฿3.84 | x |
| 2022-12-31 | ฿0.45 | ฿3.84 | x |
| 2023-12-31 | ฿2.63 | ฿3.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bangkok Lab & Cosmetic PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.23%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.34%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 1.42x
- Recent ROE (9.23%) is below the historical average (27.37%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 26.03% | 4.75% | 1.01x | 5.44x | ฿31.78 Million |
| 2022 | 46.87% | 10.15% | 1.02x | 4.52x | ฿98.89 Million |
| 2023 | 9.23% | 10.34% | 0.63x | 1.42x | ฿-12.17 Million |
Industry Comparison
This section compares Bangkok Lab & Cosmetic PCL's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $699,544,981
- Average return on equity (ROE) among peers: 34.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bangkok Lab & Cosmetic PCL (BLC) | ฿1.63 Billion | 26.03% | 0.33x | $12.24 Million |
| 88(Thailand) Public Company Limited (88TH) | $221.11 Million | 25.22% | 0.28x | $15.31 Million |
| Asian Phytoceuticals Public Company Limited (APCO) | $610.51 Million | 13.25% | 0.11x | $16.52 Million |
| Do Day Dream Public Company Limited (DDD) | $374.95 Million | 87.48% | 1.07x | $16.05 Million |
| Jack Chia Industries (Thailand) Public Company Limited (JCT) | $1.31 Billion | 6.77% | 0.23x | $6.30 Million |
| Karmarts Public Company Limited (KAMART) | $107.26 Million | 73.53% | 13.45x | $183.04 Million |
| Rojukiss International Public Company Limited (KISS) | $1.09 Billion | 12.03% | 0.29x | $24.62 Million |
| Moong Pattana International Public Company Limited (MOONG) | $736.89 Million | 17.52% | 0.30x | $6.29 Million |
| Neo Corporate Pcl (NEO) | $1.57 Billion | 52.93% | 3.65x | $52.82 Million |
| Nutrition Profess Public Company Limited (NUT) | $279.67 Million | 19.72% | 0.77x | $1.15K |